Importantly, AGR2 protein concentrations are found to be significantly elevated in serum and/or plasma samples of ovarian [17,22], lung [23] and prostate [24] cancer patients compared to healthy controls proposing AGR2 as a putative cancer serum biomarker in these tumour entities. The gene discussed is AGR2; the disease is neoplasm.